)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Hualan Biological Engineering
Hualan Biological Engineering (002007) investor relations material
Hualan Biological Engineering Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary27 Oct, 2026
Executive summary
Q3 revenue fell 35.75% YoY to ¥1.016bn; attributable net profit declined 82.41% to ¥47.25m. YTD revenue was ¥2.582bn, down 23.58%, and attributable net profit was ¥430.60m, down 45.11%.
YTD plasma collection volume increased 15% YoY, while higher VAT, weaker market demand and lower influenza-vaccine pricing pressured results.
Financial highlights
Q3 attributable net profit excluding non-recurring items was ¥42.03m, down 83.74% YoY; YTD adjusted attributable net profit was ¥383.98m, down 48.28%.
YTD operating profit was ¥549.73m versus ¥1.008bn a year earlier; consolidated net profit was ¥429.06m versus ¥827.70m.
YTD operating cash flow was ¥372.65m, down 17.30% YoY.
Segment performance
Plasma collection volume rose 15% YoY in 9M 2026, supporting future development capacity.
Investee Hualan Ankang reported 9M revenue of ¥268.17m, up 35.76%; bevacizumab sales were ¥240.84m, up 81.86%, and net profit was ¥18.16m.
Influenza-vaccine offerings shifted from quadrivalent to trivalent for the season, with corresponding terminal price adjustments and discounted supply for a rural free-vaccination program targeting older adults and children.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hualan Biological Engineering
- Revenue and profit fell amid industry headwinds, but cash flow and dividends remained strong.002007
Q2 2026 - Revenue and profit fell sharply year-over-year amid regulatory and tax changes.002007Q1 2026
- 2025 revenue rose 4.93% to ¥4.60B, net profit fell 13.55% to ¥940M, dividend payout 97%.002007H2 2025
- Q3 2025 saw a 14% revenue drop and 44.45% net profit decline year-over-year.002007Q3 2025
- Net profit rose 17.2% year-over-year on strong blood product sales and higher R&D investment.002007H1 2025
- Revenue and profit fell in Q3 2024, with cash flow and working capital under pressure.002007Q3 2024
- Revenue up, profit down as vaccine sales drop and blood products drive growth.002007H1 2024
- Revenue and net profit rose, but cash flow weakened amid higher investment outflows.002007Q1 2025
- Net profit fell 26.6% as vaccine sales dropped, but blood products revenue grew 10.9%.002007H2 2024
Next Hualan Biological Engineering earnings date
Q4 202626 Mar, 2027
Hualan Biological Engineering
Next Hualan Biological Engineering earnings date
Q4 202626 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)